“…Considerable research efforts have been devoted to synthesizing thiazole, quinazoline derivatives, and their moieties because of their widespread applications of biological merit [ 1 , 2 , 3 , 4 ]. Thiazole and quinazoline exist in condensed fused systems such as thiazolo[3,2- a ]quinazoline, thiazolo[4,3- b ]quinazoline, thiazolo[2,3- b ]quinazoline, 8 H -thiazolo[5,4- f ]quinazolin-9-ones, thiazolo[4,5- h ]quinazolin, and thiazolo[5,4- c ]quinoline which leads to them exhibiting their properties as important synthetic targets [ 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 ] due to their biological and pharmacological efficiency, such as DYRKIA inhibitors [ 15 ], HIV-1integrase inhibition [ 16 ], antimalarial [ 17 ], anticancer [ 18 , 19 , 20 ], anti-inflammatory [ 20 , 21 ], antituberculosis [ 22 ], antidepressant [ 23 ], anticonvulsant [ 24 ], antifungal [ 25 ], antihistamine [ 26 ], and antitumor [ 10 , 27 , 28 , 29 ] activity. In addition, these compounds play an important role by providing a new molecular framework for drug discovery [ 30 ].…”